Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) Share Price
Stocks
RMDA
EGS381B1C015
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
05/10/2026
|
5-day change | 1st Jan Change | ||
| 5.480 EGP | -1.26% |
|
+3.40% | +64.56% |
| Market Cap | 11.14B 213M 190M 177M 161M 303M 20.48B 305M 2.14B 831M 10.45B 798M 781M 33.6B | P/E 2026 * |
19.9x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13.24B 253M 225M 210M 191M 360M 24.34B 363M 2.54B 988M 12.42B 949M 928M 39.94B | EV / Sales 2026 * |
2.73x | EV / Sales 2027 * | 2.27x |
| Free-Float |
40.82% | Yield 2026 * |
1.42% | Yield 2027 * | 2.75% |
Latest news: Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
| 1 day | -1.26% | ||
| 1 week | +3.40% | ||
| Current month | +2.43% | ||
| 1 month | -8.67% | ||
| 3 months | +9.38% | ||
| 6 months | +31.73% | ||
| Current year | +64.56% |
| 1 week | 5.09 |  | 5.62 |
| 1 month | 4.83 | | 6.55 |
| Current year | 3.06 | | 7.39 |
| 1 year | 3.06 | | 7.39 |
| 3 years | 0.99 | | 7.39 |
| 5 years | 0.8 | | 7.39 |
| 10 years | 0.8 | | 7.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 31/12/2010 |
Aboamira Mohamed
DFI | Director of Finance/CFO | - | 31/07/2014 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 31/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karim Zahran
BRD | Director/Board Member | 41 | 31/12/2017 |
Ayman Abbas
CHM | Chairman | 51 | 31/12/2010 |
Amr Morsy
BRD | Director/Board Member | - | 31/12/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.26% | +3.40% | +69.47% | +418.85% | 216M | |
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | |
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | |
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | |
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | |
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | |
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | |
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | |
| Average | +0.07% | -3.01% | +29.87% | +93.43% | 369.74B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.84B 92.44M 82.47M 76.83M 69.92M 132M 8.9B 133M 928M 361M 4.54B 347M 340M 14.61B | 5.66B 108M 96.4M 89.81M 81.73M 154M 10.41B 155M 1.09B 422M 5.31B 406M 397M 17.07B |
| Net income | 568M 10.84M 9.67M 9.01M 8.2M 15.43M 1.04B 15.55M 109M 42.34M 533M 40.68M 39.8M 1.71B | 799M 15.25M 13.6M 12.67M 11.53M 21.72M 1.47B 21.88M 153M 59.58M 750M 57.24M 56.01M 2.41B |
| Net Debt | 2.1B 40.12M 35.79M 33.35M 30.35M 57.15M 3.86B 57.57M 403M 157M 1.97B 151M 147M 6.34B | 1.72B 32.88M 29.33M 27.33M 24.87M 46.83M 3.17B 47.18M 330M 128M 1.62B 123M 121M 5.19B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | EGP 5.480 | -1.26% | 2,832,107 |
| 04/10/26 | EGP 5.550 | +1.83% | 4,036,126 |
| 01/10/26 | EGP 5.450 | +1.87% | 7,195,956 |
| 30/09/26 | EGP 5.350 | +1.13% | 5,937,075 |
| 29/09/26 | EGP 5.290 | -0.19% | 5,605,605 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMDA Stock
Select your edition
All financial news and data tailored to specific country editions
